
    
      To assess the safety of intravenous acetaminophen (IV APAP) when used over one or more days
      for the treatment of acute pain or fever in pediatric (neonates, infants, children and
      adolescents) inpatients who are unable to take anything by mouth (NPO), require or would
      benefit from IV treatment, or are willing and able to stay on IVAPAP therapy for 1 to 7 days.
    
  